Review of Antiviral Activities Present in some Indian Medicinal Plants – Can they be used against SARS-CoV-2?
DOI:
https://doi.org/10.21276/j6nnm178Keywords:
Indian medicinal plants, SARS-CoV-2, COVID-19, infectious disease, antiviralAbstract
COVID-19 has quickly emerged as a global concern, affecting the lives of millions across the globe. It has got a different impact in different nations based on their cultural norms, mitigation strategies and healthcare architecture. In India, quite a vast majority depends on traditional Indian medicine for treatment of human illnesses due to low-cost, easier availability favorable side-effect profile. These medicines are made from herbal plants. Researchers have identified various properties of plant materials such as anti-inflammatory, antibiotic, antioxidant, antidiabetic, anti-cancerous and many more. Novels antiviral may be developed from these resources. The present study reviews the antiviral properties of ten Indian medicinal plants, namely Ailanthus excelsa, Alstonia scholaris, Nigella sativa, Adhatoda vasica, Albizia lebbeck, Andrographis paniculate, Glycyrrhiza glabra, Moringa oleifera, Ocimum basilicum and Tinospora cordifolia. Probable therapeutic roles of these plants against SARS-CoV-2 should also be explored.
Downloads
References
The Ayurvedic Pharmacopoeia of India. The controller of publications, Delhi-110054, Part-1, Vol-III, 1st ed. 2001 pp. 15-16.
Indian Pharmacopoeia. Government of India 2. Ministry of Health and Family Welfare, Controller of Publications, New Delhi, A-53-54, A-95-97, A-109.
Kumar D, Bhat ZA, Singh P, Khatanglakar V, Bhujbal SS. Antiasthmatic and antiallergic potential of methanolic extract of leaves of Ailanthus excelsa. Revista Brasileira de Farmacognosia. 2011 Feb;21(1):139-45.
Ogura M, Cordell GA, Kinghorn A, Farnsworth NR. Potential anticancer agents VI. Constituents of Ailanthus excelsa. Lloydia 1977;40:579-84.
Polonsky J. Quassinoid bitter principle—II. Fortschr Chem Org Naturst 1985;47:237.
Joshi BC, Pandey A, Sharma RP, Khare A. Quassinoids from Ailanthus excelsa. Phytochemistry. 2003;62(4):579‐584.
Rashed K, Said A, Ahmed M. Antiviral Activity and Phytochemical Analysis of Ailanthus Excelsa Roxb Bark. Journal of Forest Products and Industries 2013;2(3):30-3.
Arora A, Rai Y. A review: phytochemistry, ethanobotanical and pharmacological activities of Alstonia scholaris R. Br (Apocynaceae). Int J Adv Res 2015;3:584–590.
Pandey K, Shevkar C, Bairwa K, Kate AS. Pharmaceutical perspective on bioactives from Alstonia scholaris: ethnomedicinal knowledge, phytochemistry, clinical status, patent space, and future directions. Phytochem Rev Springer, Published online 14 feb, 2020. https://doi.org/10.1007/s11101-020-09662-z(0123
Zhang L, Zhang CJ, Zhang DB, Wen J, Zhao XW, Li Y, et al. An unusual indole alkaloid
with anti-adenovirus and anti-HSV activities from Alstonia scholaris. Tetrahedron Lett
;55(10):1815-7.
Panda SK, Padhi L, Leyssen P, Liu M, Neyts J, Luyten W. Antimicrobial, Anthelmintic, and Antiviral Activity of Plants Traditionally Used for Treating Infectious Disease in the Similipal Biosphere Reserve, Odisha, India. Front Pharmacol. 2017;8:658. doi:10.3389/fphar.2017.00658
Nguyen PQ, Ooi JS, Nguyen NT, et al. Antiviral Cystine Knot α-Amylase Inhibitors from Alstonia scholaris. J Biol Chem. 2015;290(52):31138‐31150. doi:10.1074/jbc.M115.654855
Chopra R, Nayar S, Chopra I. In: Glossary of Indian medicinal plants. New Delhi, India: CSIR, 1956. p. 175.
Nadkarni K. Crocus sativus, Nigella sativa. In: Nadkarni KM, editor. Indian materia medica. Bombay, India: Popular Prakashan, 1976. p. 386-411.
Attar-ur-Rahman, Malik S, Cunheng H, Clardy J. Isolation and structure of determination of nigellicine, a novel alkaloid from the seeds of Nigella sativa. Tetrahedron Lett 1985;26:2759-62.
Salem ML, Hossain MS. Protective effect of black seed oil from Nigella sativa against murine cytomegalovirus infection. Int J Immunopharmacol. 2000;22(9):729‐740. doi:10.1016/s0192-0561(00)00036-9
Kawther S. Zaher, W.M. Ahmed and Sakina N. Zerizer, Observations on the Biological Effects of Black Cumin Seed (Nigella sativa) and Green Tea (Camellia sinensis) Global Veterinaria 2008;2(4):198-204.
Oyero OG, Toyama M, Mitsuhiro N, et al. SELECTIVE INHIBITION OF HEPATITIS C VIRUS REPLICATION BY ALPHA-ZAM, A NIGELLA SATIVA SEED FORMULATION. Afr J Tradit Complement Altern Med. 2016;13(6):144‐148. Published 2016 Sep 29. doi:10.21010/ajtcam.v13i6.20
Santosh Kumar Singh, Dr. Jay Ram Patel, Arvind Dangi, Deepak Bachle and Rahul Kumar Kataria, A complete over review on Adhatoda vasica a traditional medicinal plant, Journal of Medicinal Plants Studies 2017; 5(1): 175-180
Rachana, Mamta Pant and Sujata Basu, Cytoprotective Activity of Adhatoda Vasica Extract and Vasicine Against Tobacco Smoke Induced Cytotoxicity, Journal of Pharmaceutical Technology, Research and Management Vol. 1 May 2013 pp. 109–117
Rana Adhikary et al, Immunomodulatory and antioxidant properties of methanolic extract of Adhatoda vasica Nees leaf after particulate antigen stimulation in miceJournal of Pharmacy Research 2014,8(10),1520-1537
Sulekha Chaudhary et al Experimental Model of Albizia lebbeck in Bronchial Asthma The Indian Journal of Chest Diseases & Allied Sciences ,2018;Vol.60
Maya C. Et. Al., Comparative Immunomodulator Activity Of Leaves And Bark Of Albizia Lebbeck (Linn.) Benth. Int. J. Res. Dev. Pharm. L. Sci.March-April 2012, 1(1), 21-23
Meshram et al.: Central analgesic activity of Albizia lebbeck leaves Z. Naturforsch. 2015; 70(1-2)c: 25–30
Chandrabhan Seniya et al./Analyzing the interaction of an herbal compound Andrographolide from Andrographis paniculata as a folklore against swine flu (H1N1), Asian Pac J Trop Dis 2014; 4(Suppl 2): S624-S630
Downloads
Published
Issue
Section
License
Copyright (c) 2024 International Archives of BioMedical and Clinical Research (IABCR)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors are required to sign and submit the completed “Copyright transfer Form” upon acceptance of publication of the paper. This is determined by a publishing agreement between the author and International Archives of Biomedical and Clinical Research. These rights might include the right to publish, communicate and distribute online. Author(s) retain the copyright of their work. International Archives of Biomedical and Clinical Research supports the need for authors to share, disseminate and maximize the impact of their research.
